The physiology, pathology and potential therapeutic application of serotonylation

J Cell Sci. 2021 Jun 1;134(11):jcs257337. doi: 10.1242/jcs.257337. Epub 2021 Jun 4.

Abstract

The classical neurotransmitter serotonin or 5-hydroxytryptamine (5-HT), synthesized from tryptophan, can be produced both centrally and peripherally. Through binding to functionally distinct receptors, serotonin is profoundly implicated in a number of fundamental physiological processes and pathogenic conditions. Recently, serotonin has been found covalently incorporated into proteins, a newly identified post-translational modification termed serotonylation. Transglutaminases (TGMs), especially TGM2, are responsible for catalyzing the transamidation reaction by transferring serotonin to the glutamine residues of target proteins. Small GTPases, extracellular matrix protein fibronectin, cytoskeletal proteins and histones are the most reported substrates for serotonylation, and their functions are triggered by this post-translational modification. This Review highlights the roles of serotonylation in physiology and diseases and provides perspectives for pharmacological interventions to ameliorate serotonylation for disease treatment.

Keywords: 5-Hydroxytryptamine; Cystamine; Deamidation; Monoaminylation; Serotonergic systems; Serotonin; Serotonin-selective reuptake inhibitors; TGase activity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Glutamine
  • Monomeric GTP-Binding Proteins*
  • Protein Processing, Post-Translational
  • Serotonin / metabolism
  • Transglutaminases* / genetics

Substances

  • Glutamine
  • Serotonin
  • Transglutaminases
  • Monomeric GTP-Binding Proteins